Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TyRx’s Drug-Coated Mesh Targets Infection After Pacemaker/ICD Implantation

This article was originally published in The Gray Sheet

Executive Summary

TyRx Pharma's Pivit CRM antibiotic-eluting mesh pouch, designed to enclose a pacemaker or ICD, aims to prevent the infrequent but serious problem of post-implant infections

You may also be interested in...



People In Brief

Alpine Biomed Appoints CEO: John Arnott takes the top spot at the gastroenterology and neurology diagnostic product firm Aug. 14. Arnott has more than 20 years experience in global healthcare organizations, including leadership positions at Hospira, Abbott Laboratories, Wellcome Diagnostics and the National Health Service in the United Kingdom. Alpine's gastro products diagnose gastroesophageal reflux disease while the neuro products are for conditions such as carpal tunnel syndrome and sleep disorders. The Fountain Valley, Calif. company recently purchased certain neuropathy diagnostics from Medtronic (1"The Gray Sheet" Aug. 6, 2007, p. 13)...

EWG Study Suggests More Than One In 10 Talc-Based Cosmetics Contain Asbestos

The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel